Tech Company Financing Transactions

Thesan Pharmaceuticals Funding Round

On 2/25/2014, Thesan Pharmaceuticals announced $49 million in Series B funding from Novo Ventures, Lundbeckfond Ventures and Novartis Venture Fund.

Transaction Overview

Announced On
2/25/2014
Transaction Type
Venture Equity
Amount
$49,000,000
Round
Series B
Investors

Novo Ventures (Lead Investor) (Peter Bisgaard)

Lundbeckfond Ventures (Mette Agger)

Novartis Venture Fund (Giovanni Ferrara)

SV Health Investors (Tracy Saxton)

Proceeds Purpose
We are very pleased with the deep financial backing provided by four top tier venture funds, which puts us in an unparalleled position as a biopharma to develop new drugs in this area.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
5864 Owens Ave. 200
Carlsbad, CA 92008
USA
Phone
Undisclosed
Email Address
Overview
Thesan Pharmaceuticals, Inc. is a preclinical biopharmaceutical company dedicated to the development of novel therapeutics for disorders of the skin. Thesan is focused on the discovery and development of New Chemical Entities that have the potential to provide significantly improved treatment options to patients.
Profile
Thesan Pharmaceuticals LinkedIn Company Profile
Social Media
Thesan Pharmaceuticals Company Twitter Account
Company News
Thesan Pharmaceuticals News
Facebook
Thesan Pharmaceuticals on Facebook
YouTube
Thesan Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Bernard King
  Bernard King LinkedIn Profile  Bernard King Twitter Account  Bernard King News  Bernard King on Facebook
Chief Financial Officer
Leslie Schulze
  Leslie Schulze LinkedIn Profile  Leslie Schulze Twitter Account  Leslie Schulze News  Leslie Schulze on Facebook
Chief Medical Officer
Howard Welgus
  Howard Welgus LinkedIn Profile  Howard Welgus Twitter Account  Howard Welgus News  Howard Welgus on Facebook
Executive Vice President
George Mooney
  George Mooney LinkedIn Profile  George Mooney Twitter Account  George Mooney News  George Mooney on Facebook
VP - Product Management
Jay Birnbaum
  Jay Birnbaum LinkedIn Profile  Jay Birnbaum Twitter Account  Jay Birnbaum News  Jay Birnbaum on Facebook
VP - Regulatory Affairs
Charlotte Merritt
  Charlotte Merritt LinkedIn Profile  Charlotte Merritt Twitter Account  Charlotte Merritt News  Charlotte Merritt on Facebook


 

 

Browse more venture capital transactions:

Prev: 2/25/2014: TPI Composites venture capital transaction
Next: 2/25/2014: Saisei venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on every notable VC transaction. VC transactions reported here are derived from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary